KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Payables: 2009-2025

Historic Payables for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $1.5 billion.

  • Quest Diagnostics' Payables rose 10.97% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 billion, marking a year-over-year increase of 5.99%. This contributed to the annual value of $1.4 billion for FY2024, which is 2.58% up from last year.
  • According to the latest figures from Q3 2025, Quest Diagnostics' Payables is $1.5 billion, which was up 8.01% from $1.3 billion recorded in Q2 2025.
  • Over the past 5 years, Quest Diagnostics' Payables peaked at $1.6 billion during Q3 2021, and registered a low of $1.2 billion during Q3 2023.
  • Its 3-year average for Payables is $1.3 billion, with a median of $1.3 billion in 2025.
  • Per our database at Business Quant, Quest Diagnostics' Payables spiked by 58.92% in 2021 and then decreased by 22.41% in 2023.
  • Over the past 5 years, Quest Diagnostics' Payables (Quarterly) stood at $1.6 billion in 2021, then dropped by 12.75% to $1.4 billion in 2022, then decreased by 2.65% to $1.4 billion in 2023, then grew by 2.58% to $1.4 billion in 2024, then climbed by 10.97% to $1.5 billion in 2025.
  • Its last three reported values are $1.5 billion in Q3 2025, $1.3 billion for Q2 2025, and $1.3 billion during Q1 2025.